Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
Key facts
- Who runs it
- Turku University Hospital
- Where
- Finland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 6,000 people, planned
- Started
- 27 Oct 2025
- Planned end
- 31 Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Possibility to get live attenuated nasal influenza vaccine at daycare
- Record updated
- 22 January 2026
Who can take part
- Age
- 2 years to 6 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Attending early childhood education (daycare) in the city of Turku
Who cannot take part
- No exclusion criteria
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 2 and 6 years old?
This trial is currently available in Finland.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this intervention study is to learn if giving children influenza vaccinations in early childhood education facilities (i.e., daycare) will increase vaccination coverage compared to giving vaccinations only at healthcare. The main question it aims to answer is:
Read full original descriptionShow less
• Does offering children nasal influenza vaccine in daycare result in higher proportion of children getting influenza vaccine.
Researchers will compare daycare setting and healthcare setting as the location of giving influenza vaccines to children to see if more children will get vaccinated if they have an opportunity to receive nasal influenza vaccine at daycare.
Participants in the intervention group will:
• Have the opportunity to receive influenza vaccine in the daycare or in the healthcare
Participants in the comparison group will:
• Have the opportunity to receive influenza vaccine in the healthcare only
The 2 groups in the trial
- Intervention groupTreatment being tested
Participants are offered a nasal influenza vaccine at daycare
Treatment: Possibility to get live attenuated nasal influenza vaccine at daycare
- Comparison groupNo study treatment, for comparison
Participants are not offered a nasal influenza vaccine at daycare
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07310472, who can take part
- Record updated
- 22 January 2026